发明名称 |
FC GAMMA RECEPTOR IIB VARIANTS |
摘要 |
The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient, wherein the method comprises providing a pharmaceutical composition containing a therapeutically effective amount of soluble FcγR; administering said composition to a patient, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two weekly administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. The present invention also provides a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble FcγR for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient. |
申请公布号 |
EP2914624(A1) |
申请公布日期 |
2015.09.09 |
申请号 |
EP20130798258 |
申请日期 |
2013.10.30 |
申请人 |
SUPPREMOL GMBH |
发明人 |
SONDERMANN, PETER;TER MEER, DOMINIK;POHL, THOMAS;WINTER, RENO;JACOB, UWE |
分类号 |
C07K14/735;A61K38/17 |
主分类号 |
C07K14/735 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|